TY - JOUR KW - Biomarkers KW - Case-Control Studies KW - *Hodgkin Disease/diagnosis KW - Humans KW - Odds Ratio KW - Primary health care KW - United Kingdom/epidemiology KW - Hodgkin lymphoma KW - blood tests KW - diagnostic time window KW - general practice KW - inflammatory markers AU - M. Rafiq AU - G. Abel AU - C. Renzi AU - G. Lyratzopoulos AD - Institute of Epidemiology and Health Care, UCL, London. University of Exeter Medical School, Exeter. AN - 35817582 BT - Br J Gen Pract C2 - PMC9282809 DO - 10.3399/bjgp.2021.0617 DP - NLM ET - 2022/07/12 LA - eng M1 - 721 N1 - 1478-5242 Rafiq, Meena Abel, Gary Renzi, Cristina Lyratzopoulos, Georgios Journal Article Br J Gen Pract. 2022 Jul 28;72(721):e546-e555. doi: 10.3399/BJGP.2021.0617. Print 2022 Aug. PY - 2022 SN - 0960-1643 (Print) 0960-1643 SP - e546 EP - e555 T2 - Br J Gen Pract TI - Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case-control study in patients aged ≤50 years VL - 72 ER -